TY - JOUR
T1 - Fish odour syndrome with features of both primary and secondary trimethylaminuria
AU - Fraser-Andrews, E. A.
AU - Manning, N. J.
AU - Ashton, G. H.S.
AU - Eldridge, P.
AU - McGrath, J. A.
AU - Menagé, H. D.P.
PY - 2003/3
Y1 - 2003/3
N2 - We report a patient with the fish odour syndrome who has both primary and secondary trimethylaminuria. The diagnosis was made using biochemical and genetic analysis in the apparent absence of any characteristic smell. Differentiation of primary and secondary trimethylaminuria is usually made on urinary analysis of trimethylamine and its metabolite trimethylamine N-oxide, with different, characteristic patterns of both compounds in primary and secondary trimethylaminuria. Our patient had biochemical analysis consistent with a diagnosis of secondary trimethylaminuria, while analysis of the flavin-containing mono-oxygenase 3 gene, the causative gene in primary trimethylaminuria, demonstrated three sequence polymorphisms, two of which are known to reduce enzyme activity. The patient showed temporary clinical and biochemical response to treatment with metronidazole and neomycin. It is important to be aware of this diagnosis in patients without obvious clinical signs, and of the subjective benefits of treatment.
AB - We report a patient with the fish odour syndrome who has both primary and secondary trimethylaminuria. The diagnosis was made using biochemical and genetic analysis in the apparent absence of any characteristic smell. Differentiation of primary and secondary trimethylaminuria is usually made on urinary analysis of trimethylamine and its metabolite trimethylamine N-oxide, with different, characteristic patterns of both compounds in primary and secondary trimethylaminuria. Our patient had biochemical analysis consistent with a diagnosis of secondary trimethylaminuria, while analysis of the flavin-containing mono-oxygenase 3 gene, the causative gene in primary trimethylaminuria, demonstrated three sequence polymorphisms, two of which are known to reduce enzyme activity. The patient showed temporary clinical and biochemical response to treatment with metronidazole and neomycin. It is important to be aware of this diagnosis in patients without obvious clinical signs, and of the subjective benefits of treatment.
UR - http://www.scopus.com/inward/record.url?scp=0344837748&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0344837748&partnerID=8YFLogxK
U2 - 10.1046/j.1365-2230.2003.01230.x
DO - 10.1046/j.1365-2230.2003.01230.x
M3 - Article
C2 - 12653714
AN - SCOPUS:0344837748
SN - 0307-6938
VL - 28
SP - 203
EP - 205
JO - Clinical and Experimental Dermatology
JF - Clinical and Experimental Dermatology
IS - 2
ER -